N
Nasus Pharma Ltd
AMEX:NSRX
Nasus Pharma Ltd
AMEX:NSRX
Price:
3.165
USD
-0.47%
Market Closed
Market Cap:
$37.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
N
|
Nasus Pharma Ltd
AMEX:NSRX
|
IL |
|
Himax Technologies Inc
NASDAQ:HIMX
|
TW |
|
Henan Mingtai Al Industrial Co Ltd
SSE:601677
|
CN |
|
B
|
Bank CIMB Niaga Tbk PT
XMUN:NKX
|
ID |
|
Fortis Frontier PLC
LSE:FORF
|
UK |
|
Summarecon Agung Tbk PT
F:RZU
|
ID |
|
Diamond Citra Propertindo Tbk PT
IDX:DADA
|
ID |
|
D
|
Dynasty Ceramic PCL
SET:DCC
|
TH |
|
Velesto Energy Bhd
OTC:VLSOF
|
MY |
|
Yamaha Motor Co Ltd
TSE:7272
|
JP |
Intrinsic Value
Not Available for NSRX
There is not enough data to reliably calculate the intrinsic value for Nasus Pharma Ltd.
Do our valuations actually work? See backtest results .
Alternatives to NSRX
Fundamental Analysis
What Nasus Pharma Does
Nasus Pharma is a clinical-stage drug company that is trying to turn medicines into dry powder that can be given through the nose. Its main idea is to make treatments work faster and more reliably for emergency or hard-to-treat conditions, where speed and ease of use matter. The company is still developing its products, so it does not yet make money from selling an approved medicine.
- Headquarters
- Israel IL
- Employees
- 7
- IPO date
- Aug 13, 2025
Efficiency
Earnings Waterfall
Nasus Pharma Ltd
Nasus Pharma Ltd
